LLY

Lilly
NYSE

Real-time Quotes | Nasdaq Last Sale

163.36
-3.09
-1.86%
After Hours: 163.36 0 0.00% 16:59 07/10 EDT
OPEN
166.14
PREV CLOSE
166.45
HIGH
166.14
LOW
162.74
VOLUME
2.25M
TURNOVER
--
52 WEEK HIGH
170.75
52 WEEK LOW
101.36
MARKET CAP
156.25B
P/E (TTM)
27.08
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average LLY stock price target is 163.07 with a high estimate of 188.00 and a low estimate of 120.00.

EPS

LLY News

More
Insiders Roundup: Mastercard, Eli Lilly
GuruFocus.com · 7h ago
Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?
Is (LLY) Outperforming Other Medical Stocks This Year?
Zacks · 7h ago
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD)
Benzinga · 11h ago
Trump Will Sign Three Executive Orders On Lowering Prescription Drug Prices
-Reuter
Reuter · 1d ago
Lilly to not share early-stage data on COVID-19 antibody - Morgan Stanley
In a note, Morgan Stanley's David Risinger says Eli Lilly (LLY -1.9%) is not planning to publish results from a Phase 1 clinical trial evaluating antibody
seekingalpha · 1d ago
Eli Lilly CEO on raising $1 billion for antibiotic research: Goal is to have two to four new antibiotics by 2030
Eli Lilly CEO David Ricks joins CNBC's Meg Tirrell to discuss how biopharma firms are raising money to fund antibiotics research amid the coronavirus pandemic.
CNBC.com · 1d ago
Watch CNBC's full interview with Eli Lilly CEO on its coronavirus antibody treatment timeline
Eli Lilly CEO David Ricks joins CNBC's Meg Tirrell to discuss how biopharma firms are raising money to fund antibiotics research amid the coronavirus pandemic.
CNBC.com · 1d ago
New $1 bln fund aims to steer antibiotic companies in tough market
Reuters · 1d ago

Industry

Pharmaceuticals
-0.37%
Pharmaceuticals & Medical Research
-0.48%

Hot Stocks

Symbol
Price
%Change

About LLY

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment develops, manufactures and markets products for both food animals and companion animals. The Company's human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. The Company's animal health products segment includes products for food animals and products for companion animals. As of December 31, 2018, the Company manufactured and distributed its products through facilities in the United States, Puerto Rico and 14 other countries.
More

Webull offers kinds of Eli Lilly And Co stock information, including NYSE:LLY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LLY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LLY stock methods without spending real money on the virtual paper trading platform.